These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 17374038

  • 1. What role does measuring medication compliance play in evaluating the efficacy of naltrexone?
    Baros AM, Latham PK, Moak DH, Voronin K, Anton RF.
    Alcohol Clin Exp Res; 2007 Apr; 31(4):596-603. PubMed ID: 17374038
    [Abstract] [Full Text] [Related]

  • 2. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM, O'Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, Dackis CA.
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials.
    O'Malley SS, Rounsaville BJ, Farren C, Namkoong K, Wu R, Robinson J, O'Connor PG.
    Arch Intern Med; 2003 Jul 28; 163(14):1695-704. PubMed ID: 12885685
    [Abstract] [Full Text] [Related]

  • 5. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    O'Malley SS, Sinha R, Grilo CM, Capone C, Farren CK, McKee SA, Rounsaville BJ, Wu R.
    Alcohol Clin Exp Res; 2007 Apr 28; 31(4):625-34. PubMed ID: 17374042
    [Abstract] [Full Text] [Related]

  • 6. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes.
    Monti PM, Rohsenow DJ, Swift RM, Gulliver SB, Colby SM, Mueller TI, Brown RA, Gordon A, Abrams DB, Niaura RS, Asher MK.
    Alcohol Clin Exp Res; 2001 Nov 28; 25(11):1634-47. PubMed ID: 11707638
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM, Silverman BL, Battisti JJ, Forman R, Schweizer E, Gastfriend DR.
    Alcohol Clin Exp Res; 2011 Oct 28; 35(10):1804-11. PubMed ID: 21575016
    [Abstract] [Full Text] [Related]

  • 8. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
    Feeney GF, Connor JP, Young RM, Tucker J, McPherson A.
    Alcohol Alcohol; 2006 Oct 28; 41(3):321-7. PubMed ID: 16467406
    [Abstract] [Full Text] [Related]

  • 9. An open clinical trial of naltrexone for amphetamine dependence: compliance and tolerability.
    Jayaram-Lindström N, Wennberg P, Beck O, Franck J.
    Nord J Psychiatry; 2005 Oct 28; 59(3):167-71. PubMed ID: 16195116
    [Abstract] [Full Text] [Related]

  • 10. Predictors of compliance with naltrexone among alcoholics.
    Rohsenow DJ, Colby SM, Monti PM, Swift RM, Martin RA, Mueller TI, Gordon A, Eaton CA.
    Alcohol Clin Exp Res; 2000 Oct 28; 24(10):1542-9. PubMed ID: 11045863
    [Abstract] [Full Text] [Related]

  • 11. Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence.
    Johnson BA, Ait-Daoud N, Prihoda TJ.
    Alcohol Clin Exp Res; 2000 May 28; 24(5):737-42. PubMed ID: 10832917
    [Abstract] [Full Text] [Related]

  • 12. Naltrexone in the treatment of alcohol dependence.
    Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA, Veterans Affairs Naltrexone Cooperative Study 425 Group.
    N Engl J Med; 2001 Dec 13; 345(24):1734-9. PubMed ID: 11742047
    [Abstract] [Full Text] [Related]

  • 13. Naltrexone's effect on cue-elicited craving among alcoholics in treatment.
    Monti PM, Rohsenow DJ, Hutchison KE, Swift RM, Mueller TI, Colby SM, Brown RA, Gulliver SB, Gordon A, Abrams DB.
    Alcohol Clin Exp Res; 1999 Aug 13; 23(8):1386-94. PubMed ID: 10470982
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial.
    Galloway GP, Koch M, Cello R, Smith DE.
    BMC Psychiatry; 2005 Apr 01; 5():18. PubMed ID: 15804355
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial.
    Guardia J, Caso C, Arias F, Gual A, Sanahuja J, Ramírez M, Mengual I, Gonzalvo B, Segura L, Trujols J, Casas M.
    Alcohol Clin Exp Res; 2002 Sep 01; 26(9):1381-7. PubMed ID: 12351933
    [Abstract] [Full Text] [Related]

  • 16. Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications.
    Namkoong K, Farren CK, O'Connor PG, O'Malley SS.
    J Clin Psychiatry; 1999 Jul 01; 60(7):449-53. PubMed ID: 10453799
    [Abstract] [Full Text] [Related]

  • 17. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
    Nunes EV, Rothenberg JL, Sullivan MA, Carpenter KM, Kleber HD.
    Am J Drug Alcohol Abuse; 2006 Jul 01; 32(4):503-17. PubMed ID: 17127538
    [Abstract] [Full Text] [Related]

  • 18. Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers.
    Davidson D, Saha C, Scifres S, Fyffe J, O'Connor S, Selzer C.
    Addict Behav; 2004 Aug 01; 29(6):1253-8. PubMed ID: 15236831
    [Abstract] [Full Text] [Related]

  • 19. Measurement and prediction of medication compliance in problem drinkers.
    Feinn R, Tennen H, Cramer J, Kranzler HR.
    Alcohol Clin Exp Res; 2003 Aug 01; 27(8):1286-92. PubMed ID: 12966323
    [Abstract] [Full Text] [Related]

  • 20. Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".
    Krystal JH, Gueorguieva R, Cramer J, Collins J, Rosenheck R, VA CSP No. 425 Study Team.
    Alcohol Clin Exp Res; 2008 Jan 01; 32(1):85-91. PubMed ID: 18070245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.